These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 23490290

  • 1. Comparative effectiveness of tiotropium and ipratropium in prevention of hospital readmission for COPD: a population-based cohort study.
    Kawasumi Y, Paterson MJ, Morrow RL, Miller TA, Bassett K, Wright JM, Dormuth CR.
    Clin Ther; 2013 Apr; 35(4):523-531.e1. PubMed ID: 23490290
    [Abstract] [Full Text] [Related]

  • 2. Enhanced persistence with tiotropium compared with other respiratory drugs in COPD.
    Breekveldt-Postma NS, Koerselman J, Erkens JA, Lammers JW, Herings RM.
    Respir Med; 2007 Jul; 101(7):1398-405. PubMed ID: 17368011
    [Abstract] [Full Text] [Related]

  • 3. Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence.
    Blais L, Forget A, Ramachandran S.
    Clin Ther; 2010 Jul; 32(7):1320-8. PubMed ID: 20678680
    [Abstract] [Full Text] [Related]

  • 4. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
    Blanchette CM, Akazawa M, Dalal A, Simoni-Wastila L.
    Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388
    [Abstract] [Full Text] [Related]

  • 5. Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease.
    Lee TA, Wilke C, Joo M, Stroupe KT, Krishnan JA, Schumock GT, Pickard AS.
    Arch Intern Med; 2009 Aug 10; 169(15):1403-10. PubMed ID: 19667304
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Incorporating tiotropium into a respiratory therapist-directed bronchodilator protocol for managing in-patients with COPD exacerbations decreases bronchodilator costs.
    Drescher GS, Carnathan BJ, Imus S, Colice GL.
    Respir Care; 2008 Dec 10; 53(12):1678-84. PubMed ID: 19025702
    [Abstract] [Full Text] [Related]

  • 8. Rehospitalization risks and outcomes in COPD patients receiving maintenance pharmacotherapy.
    Dalal AA, Shah M, D'Souza AO, Crater GD.
    Respir Med; 2012 Jun 10; 106(6):829-37. PubMed ID: 22425138
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of hospitalizations, emergency department visits, and costs in a historical cohort of Texas Medicaid patients with chronic obstructive pulmonary disease, by initial medication regimen.
    Rascati KL, Akazawa M, Johnsrud M, Stanford RH, Blanchette CM.
    Clin Ther; 2007 Jun 10; 29(6):1203-13. PubMed ID: 17692734
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Additive benefits of tiotropium in COPD patients treated with long-acting beta agonists and corticosteroids.
    Perng DW, Wu CC, Su KC, Lee YC, Perng RP, Tao CW.
    Respirology; 2006 Sep 10; 11(5):598-602. PubMed ID: 16916333
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Efficacy of tiotropium bromide (Spiriva) in patients with chronic-obstructive pulmonary disease (COPD) of different severities].
    Beeh KM, Beier J, Buhl R, Stark-Lorenzen P, Gerken F, Metzdorf N, ATEM-Studiengruppe.
    Pneumologie; 2006 Jun 10; 60(6):341-6. PubMed ID: 16761228
    [Abstract] [Full Text] [Related]

  • 18. Comparison of tiotropium bromide and combined ipratropium/salbutamol for the treatment of COPD: a UK General Practice Research Database 12-month follow-up study.
    Griffin J, Lee S, Caiado M, Kesten S, Price D.
    Prim Care Respir J; 2008 Jun 10; 17(2):104-10. PubMed ID: 18385913
    [Abstract] [Full Text] [Related]

  • 19. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group.
    Maesen FP, Smeets JJ, Sledsens TJ, Wald FD, Cornelissen PJ.
    Eur Respir J; 1995 Sep 10; 8(9):1506-13. PubMed ID: 8575576
    [Abstract] [Full Text] [Related]

  • 20. Evaluating the pharmacoeconomic effect of adding tiotropium bromide to the management of chronic obstructive pulmonary disease patients in Singapore.
    Lee KH, Phua J, Lim TK.
    Respir Med; 2006 Dec 10; 100(12):2190-6. PubMed ID: 16635566
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.